Oxford Medical Diagnostics and Michell Instruments launch gas analysis partnership

Oxford Medical Diagnostics and Michell Instruments will jointly develop new industrial gas detection and measurement devices for a number of industrial applications

Oxford Medical Diagnostics (OMD), the UK developer of breath-based, medical diagnostic technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of metabolic and infectious diseases; and Michell Instruments (MI), a global leader in high-precision moisture and humidity measurement solutions, today announced a new partnership aimed at pioneering advanced laser absorption spectroscopy applications in industrial gas detection and analysis.

Under the terms of the agreement, the two companies will focus on the targeting, design and pre-commercial development of new industrial gas detection and measurement devices for various industrial purposes, using optical, acoustic, plasma emission and related spectroscopic technologies. OMD will be responsible for the design and the development, in partnership with Michell, who will be focusing on the commercialization. The partners may also involve further third parties in the future.

The new devices will integrate OMD's proprietary technologies such as Broadband Enhanced Cavity Absorption Spectroscopy (BBCEAS), Laser Cavity Enhanced Absorption Spectroscopy (CEAS) and Plasma Emission Spectroscopy, besides various non-proprietary technologies. The companies expect the first devices to be in the market in 2012.

Key industrial applications will include the detection of water in natural gas and other commercially important gases, as well as the measurement of environmentally damaging pollutants in the oil and gas industry.

"This is another exciting partnership for Oxford Medical Diagnostics, working alongside one of the global leaders in sensory and measurement solutions," said OMD's CEO, Tony Marchington. "In addition to bringing us significant revenues as we develop the company, the partnership allows us to expand our existing gas analysis and detection technologies to new markets and new industrial applications, without diverting us from our core mission of delivering breath diagnostic solutions."

"The co-operation with OMD is a great opportunity for Michell Instruments to further innovate leading gas analysis technologies, enabling us to provide an improved level of service to our customers," said Mike Bannister, CEO of Michell Instruments.

Financial terms of the agreement were not disclosed.

About Oxford Medical Diagnostics
Oxford Medical Diagnostics Ltd is developing a unique blend of technology that makes it possible to provide rapid, accurate and low-cost diagnosis and monitoring of disease and metabolic functions through the simple and non-invasive analysis of breath. Its initial objective is to bring to market a non-invasive point-of-care (at-patient) diagnostic instrument to detect diabetes - both types 1 and 2. The OMD approach is based on development of breath analysis, potentially a highly accurate method of diagnosis. In the case of diabetes, this involves the detection of acetone in the patient's breath. The company's expertise also allows it to offer an industrial gas analysis service, giving it an on-going revenue stream. Proprietary and patented technologies within OMD include Cavity Enhanced Absorption Spectroscopy (CEAS), based on tunable diode lasers, Broadband Cavity Enhanced Absorption Spectroscopy (BBCEAS), which uses super-luminescent light emitting diodes and Plasma Emission Spectroscopy (PES). OMD has already assembled a highly experienced management team whose members have excellent track records of success in company development and technology. The company has raised GBP 1.26 million in funding from its management team and private investors. It maintains close links with the University of Oxford and academics around the world. For more information: http://www.omdiagnostics.com If you would like more information please contact:

Sarah Lawrence
Michell Instruments
Lancaster Way Business Park
Ely, Cambridgeshire
CB6 3NW
UK
Tel - +44(0)1353 658 000
Fax - +44(0)1353 658 199
e-mail - sarah.lawrence@michell.com

Notes for Editors
About Michell Instruments

Established in 1974, the Michell Instruments Group of Companies brings more than 35 years of research, design and technology to the field of instrumentation and control. The current product range includes dew point transmitters, chilled mirror hygrometers, relative humidity (RH) sensors, hydrocarbon dew point analyzers, moisture in liquid analyzers and oxygen analyzers. The company serves industries as diverse as petrochemical and pharmaceutical to power generation and food processing.

Michell Instruments has three manufacturing locations: Made, The Netherlands; Lyon, France and Ely, UK. The company has an extensive network of factory trained application engineers, subsidiaries and distributors stretching across 56 countries.

Oxford Medical Diagnostics